• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

确定马流感疫苗的可接受性阈值。

Establishing an acceptability threshold for equine influenza vaccines.

作者信息

Mumford J A, Wood J

机构信息

Animal Health Trust, Newmarket, UK.

出版信息

Dev Biol Stand. 1992;79:137-46.

PMID:1286748
Abstract

Shortcomings in the original methods (based on haemagglutination of erythrocytes) used to measure potency of equine influenza vaccines and antibody responses stimulated by vaccines, coupled with the lack of a reliable challenge system in the target species, has hindered progress in identifying the antigenic content required to provide protection. Reliable methods are now available for measuring the haemagglutinin (HA) content of vaccines and the antibody responses they elicit. The development of challenge systems in the target species has allowed antibody levels consistent with protection to be identified under experimental conditions. Comparison of vaccine performance under experimental conditions and in the field suggests that exposure to a nebulised virus aerosol provides a realistic challenge for the assessment of equine influenza vaccines.

摘要

用于测量马流感疫苗效力以及疫苗激发的抗体反应的原始方法(基于红细胞血凝反应)存在缺陷,再加上缺乏针对目标物种的可靠攻毒系统,阻碍了在确定提供保护所需的抗原成分方面取得进展。现在已有可靠的方法可用于测量疫苗的血凝素(HA)含量及其引发的抗体反应。目标物种攻毒系统的开发使得在实验条件下能够确定与保护作用一致的抗体水平。实验条件下和实际应用中疫苗性能的比较表明,暴露于雾化病毒气溶胶可为评估马流感疫苗提供现实的攻毒方式。

相似文献

1
Establishing an acceptability threshold for equine influenza vaccines.确定马流感疫苗的可接受性阈值。
Dev Biol Stand. 1992;79:137-46.
2
Single radial immunodiffusion potency test for standardization of indigenous equine influenza vaccine.用于本土马流感疫苗标准化的单向放射免疫扩散效价试验。
Indian J Exp Biol. 1993 Dec;31(12):944-7.
3
Efforts to pre-empt an equine influenza epidemic.预防马流感疫情的努力。
Vet Rec. 2003 Mar 29;152(13):405-6.
4
Equine influenza vaccine performance: still learning lessons from the field.马流感疫苗的性能:仍在从实际应用中吸取经验教训。
Vet J. 2001 Mar;161(2):107-9. doi: 10.1053/tvjl.2000.0540.
5
Current perspectives on control of equine influenza.马流感防控的当前观点
Vet Res. 2004 Jul-Aug;35(4):411-23. doi: 10.1051/vetres:2004023.
6
Vaccine failure caused an outbreak of equine influenza in Croatia.疫苗失效导致克罗地亚爆发马流感。
Vet Microbiol. 2009 Jan 1;133(1-2):164-71. doi: 10.1016/j.vetmic.2008.06.009. Epub 2008 Jun 12.
7
Evidence supporting the inclusion of strains from each of the two co-circulating lineages of H3N8 equine influenza virus in vaccines.支持在疫苗中纳入H3N8马流感病毒两个共同流行谱系中每个谱系的毒株的证据。
Vaccine. 2004 Sep 28;22(29-30):4101-9. doi: 10.1016/j.vaccine.2004.02.048.
8
Efficacy of a commercial vaccine for preventing disease caused by influenza virus infection in horses.一种用于预防马流感病毒感染所致疾病的商业疫苗的效力
J Am Vet Med Assoc. 1999 Jul 1;215(1):61-6.
9
A comparison of antibody responses to commercial equine influenza vaccines following primary vaccination of Thoroughbred weanlings--a randomised blind study.对育肥马驹进行原发性疫苗接种后,比较商业马流感疫苗的抗体反应——一项随机盲法研究。
Vaccine. 2011 Nov 15;29(49):9214-23. doi: 10.1016/j.vaccine.2011.09.101. Epub 2011 Oct 5.
10
Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge.用编码血凝素(HA)或核蛋白(NP)基因的重组改良安卡拉痘苗病毒(rMVA)构建体进行免疫接种,可保护小马免受马流感病毒攻击。
Vaccine. 2006 Feb 20;24(8):1180-90. doi: 10.1016/j.vaccine.2005.08.091. Epub 2005 Sep 12.

引用本文的文献

1
Systematic Review of Equine Influenza A Virus Vaccine Studies and Meta-Analysis of Vaccine Efficacy.系统评价马流感 A 型病毒疫苗研究及疫苗效力的荟萃分析。
Viruses. 2023 Nov 28;15(12):2337. doi: 10.3390/v15122337.
2
Immunostimulating Effect of Inactivated Parapoxvirus Ovis on the Serological Response to Equine Influenza Booster Vaccination.灭活羊副痘病毒对马流感加强免疫血清学反应的免疫刺激作用
Vaccines (Basel). 2022 Dec 14;10(12):2139. doi: 10.3390/vaccines10122139.
3
Seroprevalence of Equine Influenza and Its Associated Risk Factors in Northwest Nigeria.
尼日利亚西北部马流感血清流行率及其相关危险因素
Pathogens. 2022 Nov 17;11(11):1372. doi: 10.3390/pathogens11111372.
4
An epidemiological overview of the equine influenza epidemic in Great Britain during 2019.2019 年英国马流感疫情的流行病学概述。
Equine Vet J. 2023 Jan;55(1):153-164. doi: 10.1111/evj.13874. Epub 2022 Aug 31.
5
Equine Influenza Virus and Vaccines.马流感病毒与疫苗。
Viruses. 2021 Aug 20;13(8):1657. doi: 10.3390/v13081657.
6
Immunogenicity of Calvenza-03 EIV/EHV Vaccine in Horses: Comparative In Vivo Study.卡尔文扎 - 03型马流感病毒/马疱疹病毒疫苗对马的免疫原性:体内比较研究
Vaccines (Basel). 2021 Feb 17;9(2):166. doi: 10.3390/vaccines9020166.
7
Retrospective serological survey for influenza in horses from Brazil.巴西马流感血清学回顾性调查。
Braz J Microbiol. 2021 Mar;52(1):461-466. doi: 10.1007/s42770-020-00398-8. Epub 2020 Nov 11.
8
Evaluation of a Pseudotyped Virus Neutralisation Test for the Measurement of Equine Influenza Virus-Neutralising Antibody Responses Induced by Vaccination and Infection.一种用于测量接种疫苗和感染诱导的马流感病毒中和抗体反应的假型病毒中和试验的评估。
Vaccines (Basel). 2020 Aug 21;8(3):466. doi: 10.3390/vaccines8030466.
9
Response of Sport Horses to Different Formulations of Equine Influenza Vaccine.运动马对不同配方马流感疫苗的反应。
Vaccines (Basel). 2020 Jul 10;8(3):372. doi: 10.3390/vaccines8030372.
10
Evaluation of Current Equine Influenza Vaccination Protocols Prior to Shipment, Guided by OIE Standards.在国际兽疫局标准的指导下,对马匹运输前现行的马流感疫苗接种方案进行评估。
Vaccines (Basel). 2020 Feb 29;8(1):107. doi: 10.3390/vaccines8010107.